|
- Gomekli: Uses, Dosage, Side Effects, Warnings - Drugs. com
What is Gomekli? Gomekli (mirdametinib) is an FDA-approved medication used to treat neurofibromatosis type 1 (NF1) with plexiform neurofibromas causing symptoms and cannot be surgically removed
- label - accessdata. fda. gov
GOMEKLI is a prescription medicine used to treat adults and children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas that cause symptoms and cannot
- Gomekli (mirdametinib): Uses, Side Effects, Interactions . . . - WebMD
Gomekli is a kinase inhibitor that is used for certain people with a growth of tissue that covers a nerve, called a plexiform neurofibroma The medicine blocks certain enzymes in your body known
- DailyMed - GOMEKLI- mirdametinib capsule GOMEKLI- mirdametinib tablet . . .
GOMEKLI is indicated for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable
- FDA approves Gomekli as first neurofibromatosis drug for adults
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat neurofibromatosis type 1 (NF1), a type of rare genetic disorder
- Gomekli: Uses, Side Effects, Dosage, Cost, and More - Healthline
Gomekli is a prescription drug that treats neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN) Learn about dosage, side effects, and more
- Mirdametinib - NF1 Treatment - SpringWorks Therapeutics
GOMEKLI (mirdametinib) is an oral, small molecule MEK inhibitor that is approved in the U S for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection
- Gomekli: Package Insert Prescribing Information - Drugs. com
Gomekli package insert prescribing information for healthcare professionals Includes: indications, dosage, adverse reactions and pharmacology
|
|
|